Cleerly · Series C Extension
FDA-cleared AI imaging platform that analyzes coronary CT scans to detect and characterize heart disease earlier.
Amount
$106M
Round
Series C Extension
Valuation
—
Announced
Dec 2024
Investors
Lead investor
T. Rowe PriceNotes
Lead: Insight Partners
Other Cleerly rounds
| Date | Round | Amount | |
|---|---|---|---|
| Jul 2022 | Series C | $223M | Details → |